Stock Ratings | HC Wainwright initiated coverage of Talphera (TLPH) with a buy rating and a price target of $3, implying a potential upside of 287.10%; UBS raised its price target for Corning (GLW) to $228.

DraftKings
Planet Labs PBC
ServiceTitan
Talphera
Regenxbio

DraftKings

DKNG

0.00

Planet Labs PBC

PL

0.00

ServiceTitan

TTAN

0.00

Talphera

TLPH

0.00

Regenxbio

RGNX

0.00

The ratings of major US investment banks are used to track the latest valuations and target prices on Wall Street daily, and to explore potential equity investment opportunities.

Risk warning:

Investing in small-cap stocks can be risky. Be prepared for potential challenges related to liquidity, high volatility, limited information, and financial instability. Always diversify your investments.

Today's key assessments and concerns

UBS: Maintaining a "buy" rating on DraftKings ( DraftKings(DKNG.US) ), while raising the price target from $43 to $49.

Needham: Maintaining a "buy" rating on Planet Labs ( Planet Labs PBC(PL.US) ), while raising the price target from $40 to $53.

TD Cowen: Maintaining a "buy" rating on ServiceTitan ( ServiceTitan, Inc. Class A(TTAN.US) ), while raising the price target from $110 to $125.

HC Wainwright & Co.: Initial rating for Talphera ( Talphera, Inc.(TLPH.US) ) stock at "Buy", with a target price of $3.

HC Wainwright & Co.: Maintaining a "buy" rating on Regenxbio ( REGENXBIO, Inc.(RGNX.US) ), while lowering the price target from $30 to $26.

The symbol Classification Target price Current price Percentage of potential increase/decrease (Classification) Agency
DraftKings(DKNG.US) to lift $49.0 $24.93 96.55% UBS
Planet Labs PBC(PL.US) to lift $53.0 $32.22 64.49% Needham
ServiceTitan, Inc. Class A(TTAN.US) to lift $125.0 $77.4 61.5% TD Cowen
ServiceTitan, Inc. Class A(TTAN.US) to lift $124.0 $77.4 60.21% Morgan Stanley
Iperionx Ltd. Sponsored ADR(IPX.US) to lift $55.0 $35.22 56.16% BTIG
Talphera, Inc.(TLPH.US) Initial classification $3.0 $0.775 287.1% HC Wainwright & Co.
REGENXBIO, Inc.(RGNX.US) cut $26.0 $6.08 327.63% HC Wainwright & Co.
Insmed Incorporated(INSM.US) cut $195.0 $94.22 106.96% RBC Capital
Tractor Supply Company(TSCO.US) cut $50.0 $29.78 67.9% Guggenheim
Guidewire Software, Inc.(GWRE.US) cut $225.0 $136.06 65.37% Goldman Sachs

comments:
Target price unit and current price: US Dollar;
Current price: As of the latest closing price of US stocks;
Potential percentage increase/potential decrease = (Agency target price - current price) / current price 100% (Current price = Last closing price up to the time of the count)

Lifting

UBS: Maintaining a "buy" rating on Corning ( Corning Inc(GLW.US) ), while raising the price target from $223 to $228.

RBC Capital: Maintains "Sector-matched" rating on Oracle ( Oracle Corporation(ORCL.US) ) stock, raising price target from $160 to $190

Cantor Fitzgerald: Maintaining an "overweight" rating on Oracle Oracle Corporation(ORCL.US) ) stock, while raising the price target from $229 to $284.

Truist Securities: Maintaining a "buy" rating on Snowflake Snowflake(SNOW.US) ) stock, while raising the price target from $275 to $300.

Wells Fargo: Maintaining XPO's ( XPO, Inc.(XPO.US) ) rating at "Overweight", while raising the price target from $235 to $250.

First Coverage

Roth Capital: Initial rating for Coya Therapeutics ( Coya Therapeutics, Inc.(COYA.US) ) at "Buy", with a target price of $12.

Goldman Sachs: Initial rating for Natera Natera, Inc.(NTRA.US) ) stock at "neutral", with a target price of $245.

HC Wainwright & Co.: Initial rating for Talphera ( Talphera, Inc.(TLPH.US) ) stock at "Buy", with a target price of $3.

reduction

Baird: Maintaining a "neutral" rating on Coinbase Global Coinbase(COIN.US) ) stock, while lowering its price target from $160 to $142.

Leerink Partners: Maintaining Stryker's ( Stryker Corporation(SYK.US) ) rating at "Outperforming the Market," while lowering the price target from $410 to $407.

JP Morgan: Maintaining Wealthfront's ( Wealthfront Corporation(WLTH.US) ) rating at "overweight", while lowering the price target from $13 to $12.

Editor's Note: This content was created by Saham's AI-powered SaaS tool and reviewed by our editorial team.
Risk Warning: Investing involves risk. Securities may rise, fall, or become worthless. Investing does not guarantee profits and may result in losses. Past performance is not necessarily indicative of future results. Before making any investment decision, investors should assess their financial situation, investment objectives, experience, risk tolerance, and understand the nature of the investment products and their associated risks. For more details on the nature and risks of each investment product, please read the relevant offering documents carefully. If you have any questions, it is advisable to seek independent professional advice.